These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

630 related items for PubMed ID: 18430418

  • 1. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
    Zhai Y, Gao X, Wu Q, Peng L, Lin J, Zuo Z.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):196-203. PubMed ID: 18430418
    [Abstract] [Full Text] [Related]

  • 2. Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats.
    Li X, Han J, Li L, Wang KJ, Hu SJ.
    Int J Cardiol; 2013 Oct 09; 168(4):3340-7. PubMed ID: 23664044
    [Abstract] [Full Text] [Related]

  • 3. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
    Chen HJ, Yao L, Chen TG, Yu M, Wang LH, Chen JZ.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1902-7. PubMed ID: 18067764
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
    Kang L, Ge CJ, Hu SJ.
    Pharmacology; 2007 Nov 05; 80(2-3):120-6. PubMed ID: 17534121
    [Abstract] [Full Text] [Related]

  • 5. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y, Zhang W, Zhong M, Ma X, Qi TG, Sun H.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):366-70. PubMed ID: 17456374
    [Abstract] [Full Text] [Related]

  • 6. Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.
    Geng J, Zhao Z, Kang W, Wang W, Zhang Y, Zhiming GE.
    Pharmacol Res; 2010 Jan 06; 61(1):40-7. PubMed ID: 19683055
    [Abstract] [Full Text] [Related]

  • 7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.
    Life Sci; 2006 Aug 29; 79(14):1380-90. PubMed ID: 16712874
    [Abstract] [Full Text] [Related]

  • 8. Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
    Li L, Chen GP, Yang Y, Ye Y, Yao L, Hu SJ.
    Biochem Pharmacol; 2010 Feb 01; 79(3):399-406. PubMed ID: 19800872
    [Abstract] [Full Text] [Related]

  • 9. Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA/Ras-ERK pathways.
    Takayama N, Kai H, Kudo H, Yasuoka S, Mori T, Anegawa T, Koga M, Kajimoto H, Hirooka Y, Imaizumi T.
    Hypertens Res; 2011 Mar 01; 34(3):341-7. PubMed ID: 21124329
    [Abstract] [Full Text] [Related]

  • 10. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840
    [Abstract] [Full Text] [Related]

  • 11. Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats.
    Tsutsui H, Ishibashi Y, Takahashi M, Namba T, Tagawa H, Imanaka-Yoshida K, Takeshita A.
    J Mol Cell Cardiol; 1999 Jun 30; 31(6):1203-13. PubMed ID: 10371695
    [Abstract] [Full Text] [Related]

  • 12. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
    Xu W, Song S, Huang Y, Gong Z.
    J Gastroenterol Hepatol; 2006 Aug 30; 21(8):1250-6. PubMed ID: 16872305
    [Abstract] [Full Text] [Related]

  • 13. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
    Zhao M, Zheng S, Yang J, Wu Y, Ren Y, Kong X, Li W, Xuan J.
    PLoS One; 2015 Aug 30; 10(3):e0121312. PubMed ID: 25793583
    [Abstract] [Full Text] [Related]

  • 14. [Effect of perindopril on renal interstitial fibrosis of hypertension in rats].
    Xu H, Tao LJ, Sun M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb 30; 29(1):61-4. PubMed ID: 16137008
    [Abstract] [Full Text] [Related]

  • 15. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway.
    Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, Izawa H, Nagata K, Yokota M.
    Clin Exp Pharmacol Physiol; 2006 Dec 30; 33(12):1164-71. PubMed ID: 17184496
    [Abstract] [Full Text] [Related]

  • 16. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
    Bell D, Kelso EJ, Argent CC, Lee GR, Allen AR, McDermott BJ.
    Cardiovasc Pathol; 2004 Dec 30; 13(2):71-8. PubMed ID: 15033155
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of fluvastatin on endothelium-derived hyperpolarizing factor- and nitric oxide-mediated relaxations in arteries of hypertensive rats.
    Kansui Y, Fujii K, Goto K, Abe I, Iida M.
    Clin Exp Pharmacol Physiol; 2004 Dec 30; 31(5-6):354-9. PubMed ID: 15191411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.